<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url><loc>https://aqtual.com/</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/platform</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/personalized-testing</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/partnerships</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/biospecimen-edge</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/biospecimen-services</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/about</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/newsroom</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/publications</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/contact</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/terms</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/privacy</loc><lastmod>2026-10-22</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2026-06-eular-pos1269-baseline-cfdna-active-chromatin-ra.pdf</loc><lastmod>2026-06-06</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2026-06-asco-leiomyosarcoma-checkpoint-inhibitor-resistance-cfdna.pdf</loc><lastmod>2026-06-01</lastmod></url>
  <url><loc>https://aqtual.com/media/publications/2026-03-aqtual-platform-technology-white-paper.pdf</loc><lastmod>2026-03-04</lastmod></url>
  <url><loc>https://aqtual.com/media/publications/2026-03-aqtual-ra-product-white-paper.pdf</loc><lastmod>2026-03-04</lastmod></url>
  <url><loc>https://aqtual.com/media/publications/2026-02-prima-102-clinical-study-white-paper.pdf</loc><lastmod>2026-02-01</lastmod></url>
  <url><loc>https://aqtual.com/media/publications/2026-02-aqtual-ra-treatment-selection-test-product-overview.pdf</loc><lastmod>2026-02-01</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2025-10-acr-ra-response-measures-agreement-btsdmard.pdf</loc><lastmod>2025-10-28</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2025-06-eular-prima-102-cfdna-therapy-selection-test-ra.pdf</loc><lastmod>2025-06-12</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2025-05-asco-leiomyosarcoma-checkpoint-inhibitor-benefit-cfdna.pdf</loc><lastmod>2025-05-31</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2025-05-asco-cfdnaac-colorectal-cancer-early-detection.pdf</loc><lastmod>2025-05-31</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2025-05-ccr-east-prima-102-cfdna-classifier-ra.pdf</loc><lastmod>2025-05-02</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2024-11-acr-blood-assay-predicts-tnfi-jaki-response-ra.pdf</loc><lastmod>2024-11-15</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2024-11-acr-prima-102-cfdna-classifier-ra.pdf</loc><lastmod>2024-11-15</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2024-06-eular-pos0117-blood-assay-seropositive-seronegative-ra.pdf</loc><lastmod>2024-06-13</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2024-05-ccr-east-blood-assay-predicts-tnfi-jaki-response-ra.pdf</loc><lastmod>2024-05-08</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2024-05-ccr-east-prima-102-trial-in-progress.pdf</loc><lastmod>2024-05-08</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2024-04-aacr-lung-bladder-cancer-active-chromatin-capture.pdf</loc><lastmod>2024-04-09</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2023-11-acr-oral-blood-assay-seropositive-seronegative-ra.pdf</loc><lastmod>2023-11-15</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2023-11-acr-synovial-signatures-peripheral-blood-ra.pdf</loc><lastmod>2023-11-12</lastmod></url>
  <url><loc>https://aqtual.com/media/posters/2023-11-acr-economic-burden-treatment-switching-ra.pdf</loc><lastmod>2023-11-12</lastmod></url>
</urlset>
